This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
PO112EFFICACY OF NEPA, THE FIRST COMBINATION ANTIEMETIC AGENT, IN PATIENTS WITH BREAST CANCER RECEIVING ANTHRACYCLINE/CYCLOPHOSPHAMIDE (AC) OR NON-AC CHEMOTHERAPY. (November 2015)
Record Type:
Journal Article
Title:
PO112EFFICACY OF NEPA, THE FIRST COMBINATION ANTIEMETIC AGENT, IN PATIENTS WITH BREAST CANCER RECEIVING ANTHRACYCLINE/CYCLOPHOSPHAMIDE (AC) OR NON-AC CHEMOTHERAPY. (November 2015)
Main Title:
PO112EFFICACY OF NEPA, THE FIRST COMBINATION ANTIEMETIC AGENT, IN PATIENTS WITH BREAST CANCER RECEIVING ANTHRACYCLINE/CYCLOPHOSPHAMIDE (AC) OR NON-AC CHEMOTHERAPY